Log in to save to my catalogue

Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive...

Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_923202738

Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies

About this item

Full title

Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2012-02, Vol.30 (7), p.1343-1348

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights ► VAR2CSA is the main candidate for a vaccine against pregnancy-associated malaria. ► We performed a VAR2CSA antigenic mapping to identify the shortest fragment carrying major protective epitopes. ► Id1-DBL2X is the shortest region inducing antibodies that fully block infected erythrocytes adhesion to CSA. ► Anti-Id1-DBL2X inhibitory ant...

Alternative Titles

Full title

Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_923202738

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_923202738

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2011.12.065

How to access this item